Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
19.5 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
8
Modified dose descriptor starting point:
NOAEC
Value:
2.44 mg/m³
Explanation for the modification of the dose descriptor starting point:
chronic dose oral
AF for dose response relationship:
1
Justification:
oral to inhalation
AF for differences in duration of exposure:
1
Justification:
chronic
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for other interspecies differences:
0.7
Justification:
5/7 days
AF for intraspecies differences:
3
Justification:
worker
AF for the quality of the whole database:
1
AF for remaining uncertainties:
1
Justification:
not taken into account: granulometry with only<4 % inhalable, in ordre not to add further exposure to the natural exposure to salicylates trough Food which was estimated to a range from about 10 mg to 200 mg/day salicylate in Western diets (Swain et al., 1985, Research, 85, 950-960)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
4.9 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
12
Modified dose descriptor starting point:
NOAEL
Value:
59.2 mg/kg bw/day
AF for differences in duration of exposure:
1
Justification:
chronic
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for intraspecies differences:
3
Justification:
workers also 5/7 days
AF for the quality of the whole database:
1
Justification:
human drug use
AF for remaining uncertainties:
1
Justification:
not taken into account low dermal penetration ( < 2%) in ordre not to add further exposure to the natural exposure to salicylates trough Food which was estimated to a range from about 10 mg to 200 mg/day salicylate in Western diets (Swain et al., 1985, Research, 85, 950-960)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Value:
1 180 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Dermal
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - workers

 

 


General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.475 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
Overall assessment factor (AF):
40
Modified dose descriptor starting point:
NOAEC
AF for dose response relationship:
1
Justification:
chronic
AF for differences in duration of exposure:
1
Justification:
also drug use
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for intraspecies differences:
10
Justification:
human general population
AF for the quality of the whole database:
1
Justification:
human use as drug
AF for remaining uncertainties:
1
Justification:
granulometry not taken into account; only few % inhalable
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1.25 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
Overall assessment factor (AF):
40
Modified dose descriptor starting point:
NOAEL
AF for dose response relationship:
1
AF for differences in duration of exposure:
1
Justification:
chronic
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for intraspecies differences:
10
Justification:
human general population
AF for the quality of the whole database:
1
Justification:
human experience
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1.25 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
DNEL related information
Overall assessment factor (AF):
40
Modified dose descriptor starting point:
NOAEL
AF for dose response relationship:
1
AF for differences in duration of exposure:
1
Justification:
chronic
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for intraspecies differences:
10
Justification:
general population
AF for the quality of the whole database:
1
Justification:
human experience: drug use
Acute/short term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
5.275 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
40
DNEL extrapolated from long term DNEL
Modified dose descriptor starting point:
NOAEL
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for intraspecies differences:
10
Justification:
general population

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - General Population

Population not exposed to dust, only pills.